Main > DERMATOLOGY > Psoriasis>Plaque Psoriasis (**) > Treatment > Co: USA. B. AdalimuMAb BioSimilar *

---

Co: USA. B. AdalimuMAb BioSimilar *'s subsections
(*) EU Approval Date: 2017. 08.24
Company
Developed By:
TradeMark

Co: USA. B. AdalimuMAb BioSimilar *'s products
This section has no products